Search Genes

GET /api/v1/genes/?format=api&page=113
HTTP 200 OK
Allow: GET, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "count": 35555,
    "next": "https://panelapp-aus.org/api/v1/genes/?format=api&page=114",
    "previous": "https://panelapp-aus.org/api/v1/genes/?format=api&page=112",
    "results": [
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:2073",
                "gene_name": "tripeptidyl peptidase 1",
                "omim_gene": [
                    "607998"
                ],
                "alias_name": [
                    "TPP I"
                ],
                "gene_symbol": "TPP1",
                "hgnc_symbol": "TPP1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "11:6634000-6640692",
                            "ensembl_id": "ENSG00000166340"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "11:6612763-6619461",
                            "ensembl_id": "ENSG00000166340"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2004-12-10"
            },
            "entity_type": "gene",
            "entity_name": "TPP1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "9295267",
                "18684116",
                "23418007",
                "26224725",
                "31283065"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Ceroid lipofuscinosis, neuronal, 2, MIM# 204500",
                "MONDO:0008769",
                "Spinocerebellar ataxia, autosomal recessive 7, MIM# 609270",
                "MONDO:0012235"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "TPPII"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:12016",
                "gene_name": "tripeptidyl peptidase 2",
                "omim_gene": [
                    "190470"
                ],
                "alias_name": null,
                "gene_symbol": "TPP2",
                "hgnc_symbol": "TPP2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "13:103249353-103331521",
                            "ensembl_id": "ENSG00000134900"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "13:102597003-102679958",
                            "ensembl_id": "ENSG00000134900"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1993-02-23"
            },
            "entity_type": "gene",
            "entity_name": "TPP2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "25525876",
                "25414442",
                "33586135",
                "18362329"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Immunodeficiency 78 with autoimmunity and developmental delay, MIM# 619220"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "CGI-121",
                    "CGI121"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:24259",
                "gene_name": "TP53RK binding protein",
                "omim_gene": [
                    "608680"
                ],
                "alias_name": null,
                "gene_symbol": "TPRKB",
                "hgnc_symbol": "TPRKB",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "2:73956231-73964527",
                            "ensembl_id": "ENSG00000144034"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "2:73729104-73737400",
                            "ensembl_id": "ENSG00000144034"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2006-02-02"
            },
            "entity_type": "gene",
            "entity_name": "TPRKB",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "28805828",
                "30053862"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Galloway-Mowat syndrome 5, MIM# 617731"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ90254"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:26894",
                "gene_name": "taperin",
                "omim_gene": [
                    "613354"
                ],
                "alias_name": null,
                "gene_symbol": "TPRN",
                "hgnc_symbol": "TPRN",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "9:140086069-140098645",
                            "ensembl_id": "ENSG00000176058"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "9:137191617-137204193",
                            "ensembl_id": "ENSG00000176058"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2010-03-24"
            },
            "entity_type": "gene",
            "entity_name": "TPRN",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "19603065",
                "20170898",
                "20170899",
                "23340767",
                "25129962",
                "20170899",
                "20170899",
                "27693694",
                "24285636"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Deafness, autosomal recessive 79, MIM# 613307"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "transcribed_unprocessed_pseudogene",
                "hgnc_id": "HGNC:42356",
                "gene_name": "transmembrane phosphoinositide 3-phosphatase and tensin homolog 2 pseudogene 5",
                "omim_gene": null,
                "alias_name": null,
                "gene_symbol": "TPTE2P5",
                "hgnc_symbol": "TPTE2P5",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "13:41396432-41495890",
                            "ensembl_id": "ENSG00000168852"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "13:40822296-40921749",
                            "ensembl_id": "ENSG00000168852"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2011-07-01"
            },
            "entity_type": "gene",
            "entity_name": "TPTE2P5",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [],
            "evidence": [
                "Expert Review Red",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [],
            "mode_of_inheritance": "Unknown",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "CAP-1",
                    "CD40bp",
                    "CRAF1",
                    "LAP1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:12033",
                "gene_name": "TNF receptor associated factor 3",
                "omim_gene": [
                    "601896"
                ],
                "alias_name": null,
                "gene_symbol": "TRAF3",
                "hgnc_symbol": "TRAF3",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "14:103243813-103377837",
                            "ensembl_id": "ENSG00000131323"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "14:102777476-102911500",
                            "ensembl_id": "ENSG00000131323"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1998-05-05"
            },
            "entity_type": "gene",
            "entity_name": "TRAF3",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "20832341",
                "35960817"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Immunodeficiency 132B, MIM# 621096"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "MIP-T3",
                    "DKFZP434F124",
                    "MIPT3",
                    "IFT54"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:17861",
                "gene_name": "TRAF3 interacting protein 1",
                "omim_gene": [
                    "607380"
                ],
                "alias_name": [
                    "microtubule interacting protein that associates with TRAF3"
                ],
                "gene_symbol": "TRAF3IP1",
                "hgnc_symbol": "TRAF3IP1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "2:239229082-239309541",
                            "ensembl_id": "ENSG00000204104"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "2:238320441-238400900",
                            "ensembl_id": "ENSG00000204104"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2004-03-12"
            },
            "entity_type": "gene",
            "entity_name": "TRAF3IP1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "26487268",
                "18364699",
                "21945076"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Senior-Loken syndrome 9, MIM# 616629",
                "MONDO:0014712"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "DKFZP586G0522",
                    "ACT1",
                    "CIKS"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:1343",
                "gene_name": "TRAF3 interacting protein 2",
                "omim_gene": [
                    "607043"
                ],
                "alias_name": null,
                "gene_symbol": "TRAF3IP2",
                "hgnc_symbol": "TRAF3IP2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "6:111877657-111927481",
                            "ensembl_id": "ENSG00000056972"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "6:111556454-111606278",
                            "ensembl_id": "ENSG00000056972"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2005-04-13"
            },
            "entity_type": "gene",
            "entity_name": "TRAF3IP2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "24120361",
                "31292894",
                "20660351",
                "34289170",
                "33825088",
                "33359359",
                "32350852",
                "31292894",
                "30237576",
                "28640246"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Candidiasis, familial, 8, MIM# 615527"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "RNF119",
                    "DKFZp586I021",
                    "MGC7807"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:20456",
                "gene_name": "TNF receptor associated factor 7",
                "omim_gene": [
                    "606692"
                ],
                "alias_name": null,
                "gene_symbol": "TRAF7",
                "hgnc_symbol": "TRAF7",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "16:2205699-2228130",
                            "ensembl_id": "ENSG00000131653"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "16:2155698-2178129",
                            "ensembl_id": "ENSG00000131653"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2004-06-04"
            },
            "entity_type": "gene",
            "entity_name": "TRAF7",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "32376980"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Cardiac, facial, and digital anomalies with developmental delay, MIM# 618164"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "TRIP",
                    "RNF206"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:30764",
                "gene_name": "TRAF interacting protein",
                "omim_gene": [
                    "605958"
                ],
                "alias_name": [
                    "ring finger protein 206"
                ],
                "gene_symbol": "TRAIP",
                "hgnc_symbol": "TRAIP",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "3:49866034-49894007",
                            "ensembl_id": "ENSG00000183763"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "3:49828599-49856574",
                            "ensembl_id": "ENSG00000183763"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2006-01-09"
            },
            "entity_type": "gene",
            "entity_name": "TRAIP",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "26595769"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Seckel syndrome 9, MIM# 616777"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "OIP106",
                    "KIAA1042",
                    "MILT1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:29947",
                "gene_name": "trafficking kinesin protein 1",
                "omim_gene": [
                    "608112"
                ],
                "alias_name": [
                    "OGT(O Glc NAc transferase) interacting protein 106 KDa",
                    "O-linked N-acetylglucosamine transferase interacting protein 106",
                    "milton homolog 1 (Drosophila)"
                ],
                "gene_symbol": "TRAK1",
                "hgnc_symbol": "TRAK1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "3:42055294-42267381",
                            "ensembl_id": "ENSG00000182606"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "3:42013802-42225889",
                            "ensembl_id": "ENSG00000182606"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2005-12-13"
            },
            "entity_type": "gene",
            "entity_name": "TRAK1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "28940097",
                "28364549",
                "29846532",
                "28924745"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Developmental and epileptic encephalopathy 68, MIM# 618201"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "HSP75",
                    "HSP90L"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:16264",
                "gene_name": "TNF receptor associated protein 1",
                "omim_gene": [
                    "606219"
                ],
                "alias_name": null,
                "gene_symbol": "TRAP1",
                "hgnc_symbol": "TRAP1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "16:3701640-3767598",
                            "ensembl_id": "ENSG00000126602"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "16:3651639-3717597",
                            "ensembl_id": "ENSG00000126602"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2004-07-02"
            },
            "entity_type": "gene",
            "entity_name": "TRAP1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "24152966"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Syndromic disease, MONDO:0002254, TRAP1-related"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ12716",
                    "gry",
                    "foigr"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:25751",
                "gene_name": "trafficking protein particle complex 11",
                "omim_gene": [
                    "614138"
                ],
                "alias_name": [
                    "gryzun homolog (Drosophila)",
                    "foie gras homolog (zebrafish)"
                ],
                "gene_symbol": "TRAPPC11",
                "hgnc_symbol": "TRAPPC11",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "4:184580420-184634745",
                            "ensembl_id": "ENSG00000168538"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "4:183659267-183713594",
                            "ensembl_id": "ENSG00000168538"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2011-12-12"
            },
            "entity_type": "gene",
            "entity_name": "TRAPPC11",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "23830518",
                "26322222",
                "29855340",
                "30105108"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Muscular dystrophy, limb-girdle, autosomal recessive 18, MIM# 615356"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "CGI-87",
                    "TTC-15"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:24284",
                "gene_name": "trafficking protein particle complex 12",
                "omim_gene": [
                    "614139"
                ],
                "alias_name": null,
                "gene_symbol": "TRAPPC12",
                "hgnc_symbol": "TRAPPC12",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "2:3383446-3488865",
                            "ensembl_id": "ENSG00000171853"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "2:3379675-3485094",
                            "ensembl_id": "ENSG00000171853"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2011-12-12"
            },
            "entity_type": "gene",
            "entity_name": "TRAPPC12",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "32369837",
                "28777934"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Encephalopathy, progressive, early-onset, with brain atrophy and spasticity, MIM# 617669"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "TRS20",
                    "SEDT",
                    "MIP-2A",
                    "ZNF547L",
                    "hYP38334"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:23068",
                "gene_name": "trafficking protein particle complex 2",
                "omim_gene": [
                    "300202"
                ],
                "alias_name": null,
                "gene_symbol": "TRAPPC2",
                "hgnc_symbol": "TRAPPC2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "X:13730363-13752754",
                            "ensembl_id": "ENSG00000196459"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "X:13712244-13734635",
                            "ensembl_id": "ENSG00000196459"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2005-01-26"
            },
            "entity_type": "gene",
            "entity_name": "TRAPPC2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "10431248",
                "14755465",
                "33726005",
                "20301324",
                "32953644"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Spondyloepiphyseal dysplasia tarda, MIM# 313400"
            ],
            "mode_of_inheritance": "X-LINKED: hemizygous mutation in males, biallelic mutations in females",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:23066",
                "gene_name": "trafficking protein particle complex 6B",
                "omim_gene": [
                    "610397"
                ],
                "alias_name": null,
                "gene_symbol": "TRAPPC6B",
                "hgnc_symbol": "TRAPPC6B",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "14:39617015-39639736",
                            "ensembl_id": "ENSG00000182400"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "14:39147811-39170532",
                            "ensembl_id": "ENSG00000182400"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2003-09-01"
            },
            "entity_type": "gene",
            "entity_name": "TRAPPC6B",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "28626029",
                "28397838",
                "31687267"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy, MIM# 617862"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "DR5",
                    "KILLER",
                    "TRICK2A",
                    "TRAIL-R2",
                    "TRICKB",
                    "CD262"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:11905",
                "gene_name": "TNF receptor superfamily member 10b",
                "omim_gene": [
                    "603612"
                ],
                "alias_name": null,
                "gene_symbol": "TNFRSF10B",
                "hgnc_symbol": "TNFRSF10B",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "8:22877646-22926692",
                            "ensembl_id": "ENSG00000120889"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "8:23020133-23069179",
                            "ensembl_id": "ENSG00000120889"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1998-12-04"
            },
            "entity_type": "gene",
            "entity_name": "TNFRSF10B",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "9721851"
            ],
            "evidence": [
                "Expert Review Red",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Squamous cell carcinoma, head and neck MIM#275355"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "RANK",
                    "CD265",
                    "FEO"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:11908",
                "gene_name": "TNF receptor superfamily member 11a",
                "omim_gene": [
                    "603499"
                ],
                "alias_name": null,
                "gene_symbol": "TNFRSF11A",
                "hgnc_symbol": "TNFRSF11A",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "18:59992520-60058516",
                            "ensembl_id": "ENSG00000141655"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "18:62325287-62391292",
                            "ensembl_id": "ENSG00000141655"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1998-12-04"
            },
            "entity_type": "gene",
            "entity_name": "TNFRSF11A",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "18606301",
                "32048120",
                "40222603",
                "36740137",
                "35812760",
                "33037392",
                "31163101"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Osteopetrosis, autosomal recessive 7 - MIM# 612301",
                "familial expansile osteolysis, MONDO:0008275"
            ],
            "mode_of_inheritance": "BOTH monoallelic and biallelic, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "OCIF",
                    "TR1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:11909",
                "gene_name": "TNF receptor superfamily member 11b",
                "omim_gene": [
                    "602643"
                ],
                "alias_name": null,
                "gene_symbol": "TNFRSF11B",
                "hgnc_symbol": "TNFRSF11B",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "8:119935796-119964439",
                            "ensembl_id": "ENSG00000164761"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "8:118923557-118952200",
                            "ensembl_id": "ENSG00000164761"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1997-09-05"
            },
            "entity_type": "gene",
            "entity_name": "TNFRSF11B",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "14672344",
                "24743232",
                "40735895",
                "29578045",
                "33559312",
                "33989379",
                "35412619"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "juvenile Paget disease MONDO:0009394",
                "chondrocalcinosis 1 MONDO:0010917"
            ],
            "mode_of_inheritance": "BOTH monoallelic and biallelic, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "TACI",
                    "CD267",
                    "IGAD2"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:18153",
                "gene_name": "TNF receptor superfamily member 13B",
                "omim_gene": [
                    "604907"
                ],
                "alias_name": null,
                "gene_symbol": "TNFRSF13B",
                "hgnc_symbol": "TNFRSF13B",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "17:16832849-16875432",
                            "ensembl_id": "ENSG00000240505"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "17:16929816-16972118",
                            "ensembl_id": "ENSG00000240505"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2002-05-22"
            },
            "entity_type": "gene",
            "entity_name": "TNFRSF13B",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "17392798",
                "16007086",
                "18981294",
                "16007087"
            ],
            "evidence": [
                "Expert Review Green",
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Immunodeficiency, common variable, 2, MIM# 240500"
            ],
            "mode_of_inheritance": "Other",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "BAFFR",
                    "CD268"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:17755",
                "gene_name": "TNF receptor superfamily member 13C",
                "omim_gene": [
                    "606269"
                ],
                "alias_name": null,
                "gene_symbol": "TNFRSF13C",
                "hgnc_symbol": "TNFRSF13C",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "22:42321045-42322822",
                            "ensembl_id": "ENSG00000159958"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "22:41922023-41926818",
                            "ensembl_id": "ENSG00000159958"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2002-05-22"
            },
            "entity_type": "gene",
            "entity_name": "TNFRSF13C",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "19666484",
                "26613719"
            ],
            "evidence": [
                "Expert Review Amber",
                "Expert Review Amber",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Immunodeficiency, common variable, 4, MIM# 613494"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "FRA2",
                    "FLJ23306"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:3798",
                "gene_name": "FOS like 2, AP-1 transcription factor subunit",
                "omim_gene": [
                    "601575"
                ],
                "alias_name": null,
                "gene_symbol": "FOSL2",
                "hgnc_symbol": "FOSL2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "2:28615315-28640179",
                            "ensembl_id": "ENSG00000075426"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "2:28392448-28417312",
                            "ensembl_id": "ENSG00000075426"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1996-10-02"
            },
            "entity_type": "gene",
            "entity_name": "FOSL2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "36197437"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Aplasia cutis-enamel dysplasia syndrome, MIM# 620789"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:18648",
                "gene_name": "dipeptidyl peptidase 9",
                "omim_gene": [
                    "608258"
                ],
                "alias_name": null,
                "gene_symbol": "DPP9",
                "hgnc_symbol": "DPP9",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "19:4675236-4724685",
                            "ensembl_id": "ENSG00000142002"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "19:4675224-4724673",
                            "ensembl_id": "ENSG00000142002"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2002-05-21"
            },
            "entity_type": "gene",
            "entity_name": "DPP9",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "36112693",
                "37544411"
            ],
            "evidence": [
                "Expert Review Green",
                "Expert Review"
            ],
            "phenotypes": [
                "Hatipoglu immunodeficiency syndrome MIM#620331",
                "Autoinflammatory syndrome MONDO:0019751, DPP9-related",
                "recurrent fevers",
                "repeated infections",
                "herpes susceptibility",
                "cytopenias"
            ],
            "mode_of_inheritance": "BOTH monoallelic and biallelic, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "lncRNA-N3"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:1399",
                "gene_name": "calcium voltage-gated channel auxiliary subunit alpha2delta 1",
                "omim_gene": [
                    "114204"
                ],
                "alias_name": null,
                "gene_symbol": "CACNA2D1",
                "hgnc_symbol": "CACNA2D1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "7:81575760-82073114",
                            "ensembl_id": "ENSG00000153956"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "7:81946444-82443798",
                            "ensembl_id": "ENSG00000153956"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1992-03-27"
            },
            "entity_type": "gene",
            "entity_name": "CACNA2D1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "35293990"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Developmental and epileptic encephalopathy 110, MIM#\t620149"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:8807",
                "gene_name": "pyruvate dehydrogenase E1 alpha 2 subunit",
                "omim_gene": [
                    "179061"
                ],
                "alias_name": null,
                "gene_symbol": "PDHA2",
                "hgnc_symbol": "PDHA2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "4:96761239-96762625",
                            "ensembl_id": "ENSG00000163114"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "4:95840019-95841474",
                            "ensembl_id": "ENSG00000163114"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1990-07-11"
            },
            "entity_type": "gene",
            "entity_name": "PDHA2",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "29581481",
                "35172124"
            ],
            "evidence": [
                "Expert Review Red",
                "Literature"
            ],
            "phenotypes": [
                "Spermatogenic failure-70, MIM#619828"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:4327",
                "gene_name": "glycine receptor alpha 2",
                "omim_gene": [
                    "305990"
                ],
                "alias_name": null,
                "gene_symbol": "GLRA2",
                "hgnc_symbol": "GLRA2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "X:14547420-14749934",
                            "ensembl_id": "ENSG00000101958"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "X:14529298-14731812",
                            "ensembl_id": "ENSG00000101958"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1989-05-23"
            },
            "entity_type": "gene",
            "entity_name": "GLRA2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "26370147",
                "20479760",
                "35294868"
            ],
            "evidence": [
                "Expert Review Green",
                "Expert list"
            ],
            "phenotypes": [
                "Intellectual developmental disorder, X-linked, syndromic, Pilorge type, MIM#\t301076"
            ],
            "mode_of_inheritance": "X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "HPC-1",
                    "p35-1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:11433",
                "gene_name": "syntaxin 1A",
                "omim_gene": [
                    "186590"
                ],
                "alias_name": null,
                "gene_symbol": "STX1A",
                "hgnc_symbol": "STX1A",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "7:73113536-73134002",
                            "ensembl_id": "ENSG00000106089"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "7:73699206-73719672",
                            "ensembl_id": "ENSG00000106089"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1992-09-09"
            },
            "entity_type": "gene",
            "entity_name": "STX1A",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "neurodevelopmental disorder MONDO#0700092, STX1A-related"
            ],
            "mode_of_inheritance": "BOTH monoallelic and biallelic, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "L2",
                    "hSGT2",
                    "hSgt2p",
                    "SGT2"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:9249",
                "gene_name": "PPFIA binding protein 1",
                "omim_gene": [
                    "603141"
                ],
                "alias_name": [
                    "liprin beta 1"
                ],
                "gene_symbol": "PPFIBP1",
                "hgnc_symbol": "PPFIBP1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "12:27676364-27848497",
                            "ensembl_id": "ENSG00000110841"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "12:27523431-27695564",
                            "ensembl_id": "ENSG00000110841"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1998-10-23"
            },
            "entity_type": "gene",
            "entity_name": "PPFIBP1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "35830857"
            ],
            "evidence": [
                "Expert Review Green",
                "Expert Review"
            ],
            "phenotypes": [
                "Neurodevelopmental disorder with seizures, microcephaly, and brain abnormalities, MIM# 620024"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "Kv10.2",
                    "H-EAG2",
                    "eag2"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:6254",
                "gene_name": "potassium voltage-gated channel subfamily H member 5",
                "omim_gene": [
                    "605716"
                ],
                "alias_name": null,
                "gene_symbol": "KCNH5",
                "hgnc_symbol": "KCNH5",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "14:63173287-63568755",
                            "ensembl_id": "ENSG00000140015"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "14:62699454-63102037",
                            "ensembl_id": "ENSG00000140015"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2000-02-02"
            },
            "entity_type": "gene",
            "entity_name": "KCNH5",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "Other",
            "publications": [
                "36307226"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Developmental and epileptic encephalopathy 112, MIM#\t620537"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "RNASE3L",
                    "Etohi2",
                    "HSA242976",
                    "RN3"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:17904",
                "gene_name": "drosha ribonuclease III",
                "omim_gene": [
                    "608828"
                ],
                "alias_name": [
                    "drosha, ribonuclease type III",
                    "drosha, double-stranded RNA-specific endoribonuclease"
                ],
                "gene_symbol": "DROSHA",
                "hgnc_symbol": "DROSHA",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "5:31400604-31532303",
                            "ensembl_id": "ENSG00000113360"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "5:31400497-31532196",
                            "ensembl_id": "ENSG00000113360"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2010-10-28"
            },
            "entity_type": "gene",
            "entity_name": "DROSHA",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "39654947",
                "35405010",
                "29339534"
            ],
            "evidence": [
                "Expert Review Amber",
                "Literature"
            ],
            "phenotypes": [
                "Neurodevelopmental disorder, MONDO:0700092",
                "hereditary hemorrhagic telangiectasia MONDO:0019180",
                "idiopathic spontaneous coronary artery dissection MONDO:0007385"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown",
            "tags": [
                "non-coding gene"
            ],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "TUBL3"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:12425",
                "gene_name": "tubby like protein 3",
                "omim_gene": [
                    "604730"
                ],
                "alias_name": null,
                "gene_symbol": "TULP3",
                "hgnc_symbol": "TULP3",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "12:2986389-3050306",
                            "ensembl_id": "ENSG00000078246"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "12:2877223-2941140",
                            "ensembl_id": "ENSG00000078246"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1998-05-11"
            },
            "entity_type": "gene",
            "entity_name": "TULP3",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "PMID: 35397207"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Hepatorenocardiac degenerative fibrosis, MIM# 619902"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "Dnahc14",
                    "HL-18",
                    "HL18",
                    "DKFZp781B1548",
                    "MGC27277"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:2945",
                "gene_name": "dynein axonemal heavy chain 14",
                "omim_gene": [
                    "603341"
                ],
                "alias_name": null,
                "gene_symbol": "DNAH14",
                "hgnc_symbol": "DNAH14",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "1:225083964-225586996",
                            "ensembl_id": "ENSG00000185842"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "1:224896262-225399292",
                            "ensembl_id": "ENSG00000185842"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1997-02-05"
            },
            "entity_type": "gene",
            "entity_name": "DNAH14",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "PMID: 35438214"
            ],
            "evidence": [
                "Expert Review Red",
                "ClinGen",
                "Expert Review Red",
                "Literature"
            ],
            "phenotypes": [
                "Neurodevelopmental disorder (MONDO#0700092), DNAH14-related"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [
                "disputed"
            ],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "KIAA0155",
                    "TSBP",
                    "p150TSP"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:16850",
                "gene_name": "CTR9 homolog, Paf1/RNA polymerase II complex component",
                "omim_gene": [
                    "609366"
                ],
                "alias_name": null,
                "gene_symbol": "CTR9",
                "hgnc_symbol": "CTR9",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "11:10772534-10801290",
                            "ensembl_id": "ENSG00000198730"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "11:10750987-10779743",
                            "ensembl_id": "ENSG00000198730"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2006-05-22"
            },
            "entity_type": "gene",
            "entity_name": "CTR9",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "PMID: 35499524",
                "25099282",
                "29292210"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Neurodevelopmental disorder (MONDO:0700092), CTR9 related",
                "Familial Wilms tumour, MONDO:0006058, CTR9-related"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "MUC-24",
                    "MGC-24",
                    "DFNA66"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:1632",
                "gene_name": "CD164 molecule",
                "omim_gene": [
                    "603356"
                ],
                "alias_name": [
                    "deafness, autosomal dominant 66"
                ],
                "gene_symbol": "CD164",
                "hgnc_symbol": "CD164",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "6:109687717-109703762",
                            "ensembl_id": "ENSG00000135535"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "6:109366514-109382457",
                            "ensembl_id": "ENSG00000135535"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2000-06-08"
            },
            "entity_type": "gene",
            "entity_name": "CD164",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "26197441",
                "35254497",
                "26197441"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Deafness, autosomal dominant 66, MIM# 616969"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:1763",
                "gene_name": "cadherin 4",
                "omim_gene": [
                    "603006"
                ],
                "alias_name": [
                    "R-Cadherin"
                ],
                "gene_symbol": "CDH4",
                "hgnc_symbol": "CDH4",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "20:59827482-60515673",
                            "ensembl_id": "ENSG00000179242"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "20:61252426-61940617",
                            "ensembl_id": "ENSG00000179242"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1995-08-11"
            },
            "entity_type": "gene",
            "entity_name": "CDH4",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "35034853"
            ],
            "evidence": [
                "Expert Review Red",
                "Literature"
            ],
            "phenotypes": [
                "coloboma MONDO#0001476, CDH4-related"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "EZF",
                    "GKLF"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:6348",
                "gene_name": "Kruppel like factor 4",
                "omim_gene": [
                    "602253"
                ],
                "alias_name": [
                    "gut Kruppel-like factor"
                ],
                "gene_symbol": "KLF4",
                "hgnc_symbol": "KLF4",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "9:110247133-110252763",
                            "ensembl_id": "ENSG00000136826"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "9:107484852-107490482",
                            "ensembl_id": "ENSG00000136826"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1999-12-14"
            },
            "entity_type": "gene",
            "entity_name": "KLF4",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "PMID: 35168889",
                "10431239"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Hereditary palmoplantar keratoderma MONDO:0019272, KFL4-related"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "DJ402G11.8",
                    "DKFZp434B0717",
                    "CHAMP"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7201",
                "gene_name": "Mov10 RISC complex RNA helicase like 1",
                "omim_gene": [
                    "605794"
                ],
                "alias_name": [
                    "cardiac helicase activated by MEF2C protein"
                ],
                "gene_symbol": "MOV10L1",
                "hgnc_symbol": "MOV10L1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "22:50528308-50600119",
                            "ensembl_id": "ENSG00000073146"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "22:50089879-50161690",
                            "ensembl_id": "ENSG00000073146"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2000-05-31"
            },
            "entity_type": "gene",
            "entity_name": "MOV10L1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "35476666",
                "20534472"
            ],
            "evidence": [
                "Expert Review Green",
                "Expert list"
            ],
            "phenotypes": [
                "Spermatogenic failure 73, MIM#619878"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:3607",
                "gene_name": "fructose-bisphosphatase 2",
                "omim_gene": [
                    "603027"
                ],
                "alias_name": null,
                "gene_symbol": "FBP2",
                "hgnc_symbol": "FBP2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "9:97321002-97356075",
                            "ensembl_id": "ENSG00000130957"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "9:94558720-94593793",
                            "ensembl_id": "ENSG00000130957"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1998-12-09"
            },
            "entity_type": "gene",
            "entity_name": "FBP2",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "33977262"
            ],
            "evidence": [
                "Expert Review Amber",
                "Expert list"
            ],
            "phenotypes": [
                "Leukodystrophy, childhood-onset, remitting, MIM# 619864"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "GOA",
                    "RNF100"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:19020",
                "gene_name": "tripartite motif containing 47",
                "omim_gene": [
                    "611041"
                ],
                "alias_name": null,
                "gene_symbol": "TRIM47",
                "hgnc_symbol": "TRIM47",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "17:73870242-73874656",
                            "ensembl_id": "ENSG00000132481"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "17:75874161-75878575",
                            "ensembl_id": "ENSG00000132481"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2003-01-03"
            },
            "entity_type": "gene",
            "entity_name": "TRIM47",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "35511193"
            ],
            "evidence": [
                "Expert Review Red",
                "Literature"
            ],
            "phenotypes": [
                "Genetic cerebral small vessel disease MONDO:0018787"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ20718"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:26087",
                "gene_name": "HEAT repeat containing 3",
                "omim_gene": [
                    "614951"
                ],
                "alias_name": null,
                "gene_symbol": "HEATR3",
                "hgnc_symbol": "HEATR3",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "16:50099852-50140298",
                            "ensembl_id": "ENSG00000155393"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "16:50065941-50106387",
                            "ensembl_id": "ENSG00000155393"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2006-04-05"
            },
            "entity_type": "gene",
            "entity_name": "HEATR3",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "PMID: 35213692"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Diamond Blackfan anaemia, MONDO:0015253, HEATR3 related"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ22690",
                    "IAN6"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:21918",
                "gene_name": "GTPase, IMAP family member 6",
                "omim_gene": [
                    "616960"
                ],
                "alias_name": [
                    "immune-associated nucleotide-binding protein 6"
                ],
                "gene_symbol": "GIMAP6",
                "hgnc_symbol": "GIMAP6",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "7:150322463-150329473",
                            "ensembl_id": "ENSG00000133561"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "7:150625375-150632648",
                            "ensembl_id": "ENSG00000133561"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2004-10-29"
            },
            "entity_type": "gene",
            "entity_name": "GIMAP6",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "PMID: 35551368",
                "33328581"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Autoinflammatory syndrome MONDO:0019751, GIMAP6-related"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:6648",
                "gene_name": "leiomodin 2",
                "omim_gene": [
                    "608006"
                ],
                "alias_name": null,
                "gene_symbol": "LMOD2",
                "hgnc_symbol": "LMOD2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "7:123295861-123304344",
                            "ensembl_id": "ENSG00000170807"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "7:123655807-123664290",
                            "ensembl_id": "ENSG00000170807"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2000-03-22"
            },
            "entity_type": "gene",
            "entity_name": "LMOD2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "PMID: 31517052",
                "PMID: 34888509",
                "PMID: 35082396",
                "PMID: 35188328",
                "PMID: 26487682"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Dilated cardiomyopathy, MONDO:0005021"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "hBUB1",
                    "BUB1A"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:1148",
                "gene_name": "BUB1 mitotic checkpoint serine/threonine kinase",
                "omim_gene": [
                    "602452"
                ],
                "alias_name": null,
                "gene_symbol": "BUB1",
                "hgnc_symbol": "BUB1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "2:111395275-111435691",
                            "ensembl_id": "ENSG00000169679"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "2:110637698-110678114",
                            "ensembl_id": "ENSG00000169679"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1997-08-18"
            },
            "entity_type": "gene",
            "entity_name": "BUB1",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "35044816",
                "19772675",
                "19117986",
                "23209306"
            ],
            "evidence": [
                "Expert Review Amber",
                "Literature"
            ],
            "phenotypes": [
                "Primary microcephaly-30 (MCPH30), MIM#620183"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "HATH1",
                    "MATH-1",
                    "Math1",
                    "bHLHa14"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:797",
                "gene_name": "atonal bHLH transcription factor 1",
                "omim_gene": [
                    "601461"
                ],
                "alias_name": null,
                "gene_symbol": "ATOH1",
                "hgnc_symbol": "ATOH1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "4:94750042-94751221",
                            "ensembl_id": "ENSG00000172238"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "4:93828753-93830964",
                            "ensembl_id": "ENSG00000172238"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1997-02-27"
            },
            "entity_type": "gene",
            "entity_name": "ATOH1",
            "confidence_level": "2",
            "penetrance": "unknown",
            "mode_of_pathogenicity": null,
            "publications": [
                "35518571"
            ],
            "evidence": [
                "Expert Review Amber",
                "Literature"
            ],
            "phenotypes": [
                "Pontocerebellar hypoplasia MONDO:0020135, ATOH1-related"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "PTP1E",
                    "PTP-BAS",
                    "PTPL1",
                    "PTP-BL"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:9646",
                "gene_name": "protein tyrosine phosphatase, non-receptor type 13",
                "omim_gene": [
                    "600267"
                ],
                "alias_name": [
                    "APO-1/CD95 (Fas)-associated phosphatase"
                ],
                "gene_symbol": "PTPN13",
                "hgnc_symbol": "PTPN13",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "4:87515468-87736324",
                            "ensembl_id": "ENSG00000163629"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "4:86594315-86815171",
                            "ensembl_id": "ENSG00000163629"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1995-02-17"
            },
            "entity_type": "gene",
            "entity_name": "PTPN13",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "35643866"
            ],
            "evidence": [
                "Expert Review Amber",
                "Literature"
            ],
            "phenotypes": [
                "bone marrow failure syndrome MONDO#0000159, PTPN13-related"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "KIAA0710",
                    "hPAN2"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:20074",
                "gene_name": "PAN2 poly(A) specific ribonuclease subunit",
                "omim_gene": [
                    "617447"
                ],
                "alias_name": [
                    "PAN2 homolog, PABP1 dependent poly A specific ribonuclease subunit (S. cerevisiae)"
                ],
                "gene_symbol": "PAN2",
                "hgnc_symbol": "PAN2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "12:56710007-56727837",
                            "ensembl_id": "ENSG00000135473"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "12:56316223-56334053",
                            "ensembl_id": "ENSG00000135473"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2008-01-08"
            },
            "entity_type": "gene",
            "entity_name": "PAN2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "PMID:35304602",
                "29620724"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Developmental delay with variable cardiac and renal congenital anomalies and dysmoprhic facies, MIM# 621384"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:10451",
                "gene_name": "ribonucleotide reductase catalytic subunit M1",
                "omim_gene": [
                    "180410"
                ],
                "alias_name": null,
                "gene_symbol": "RRM1",
                "hgnc_symbol": "RRM1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "11:4115937-4160106",
                            "ensembl_id": "ENSG00000167325"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "11:4094707-4138876",
                            "ensembl_id": "ENSG00000167325"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1986-01-01"
            },
            "entity_type": "gene",
            "entity_name": "RRM1",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "35617047"
            ],
            "evidence": [
                "Expert Review Amber",
                "Expert list"
            ],
            "phenotypes": [
                "Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 6, MIM# 620647"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:2236",
                "gene_name": "coatomer protein complex subunit gamma 1",
                "omim_gene": [
                    "615525"
                ],
                "alias_name": [
                    "coat protein gamma-cop"
                ],
                "gene_symbol": "COPG1",
                "hgnc_symbol": "COPG1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "3:128968449-128996614",
                            "ensembl_id": "ENSG00000181789"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "3:129249606-129277773",
                            "ensembl_id": "ENSG00000181789"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2012-02-23"
            },
            "entity_type": "gene",
            "entity_name": "COPG1",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "33529166"
            ],
            "evidence": [
                "Expert Review Amber",
                "Expert Review"
            ],
            "phenotypes": [
                "Immunodeficiency 128, MIM# 620983"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:1653",
                "gene_name": "CD28 molecule",
                "omim_gene": [
                    "186760"
                ],
                "alias_name": [
                    "T-cell-specific surface glycoprotein"
                ],
                "gene_symbol": "CD28",
                "hgnc_symbol": "CD28",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "2:204571198-204603635",
                            "ensembl_id": "ENSG00000178562"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "2:203706475-203738912",
                            "ensembl_id": "ENSG00000178562"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1988-05-11"
            },
            "entity_type": "gene",
            "entity_name": "CD28",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "34214472"
            ],
            "evidence": [
                "Expert Review Amber",
                "Expert Review"
            ],
            "phenotypes": [
                "Immunodeficiency-123 with HPV-related verrucosis (IMD123), MIM#620901",
                "isolated susceptibility to cutaneous α- and γ-HPVs"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "OBF1",
                    "BOB1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:9211",
                "gene_name": "POU class 2 associating factor 1",
                "omim_gene": [
                    "601206"
                ],
                "alias_name": null,
                "gene_symbol": "POU2AF1",
                "hgnc_symbol": "POU2AF1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "11:111222977-111326355",
                            "ensembl_id": "ENSG00000110777"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "11:111352252-111455630",
                            "ensembl_id": "ENSG00000110777"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1995-11-08"
            },
            "entity_type": "gene",
            "entity_name": "POU2AF1",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "33571536"
            ],
            "evidence": [
                "Expert Review Amber",
                "Expert Review"
            ],
            "phenotypes": [
                "Agammaglobulinaemia, MONDO:0015977, POU2AF1-related"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "APRIL",
                    "CD256"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:11928",
                "gene_name": "TNF superfamily member 13",
                "omim_gene": [
                    "604472"
                ],
                "alias_name": null,
                "gene_symbol": "TNFSF13",
                "hgnc_symbol": "TNFSF13",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "17:7461609-7464925",
                            "ensembl_id": "ENSG00000161955"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "17:7558292-7561608",
                            "ensembl_id": "ENSG00000161955"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1998-12-04"
            },
            "entity_type": "gene",
            "entity_name": "TNFSF13",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "32298700"
            ],
            "evidence": [
                "Expert Review Red",
                "Literature"
            ],
            "phenotypes": [
                "Hypogammaglobulinaemia, MONDO:0015977, TNSF13-related"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "RhoG",
                    "MGC125835",
                    "MGC125836"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:672",
                "gene_name": "ras homolog family member G",
                "omim_gene": [
                    "179505"
                ],
                "alias_name": null,
                "gene_symbol": "RHOG",
                "hgnc_symbol": "RHOG",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "11:3848208-3862213",
                            "ensembl_id": "ENSG00000177105"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "11:3826978-3840983",
                            "ensembl_id": "ENSG00000177105"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2004-03-24"
            },
            "entity_type": "gene",
            "entity_name": "RHOG",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "33513601"
            ],
            "evidence": [
                "Expert Review Amber",
                "Literature"
            ],
            "phenotypes": [
                "Genetic HLH, MONDO:0015541, RHOG-related"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ32821",
                    "TAF(II)43"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:17300",
                "gene_name": "TATA-box binding protein associated factor 8",
                "omim_gene": [
                    "609514"
                ],
                "alias_name": null,
                "gene_symbol": "TAF8",
                "hgnc_symbol": "TAF8",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "6:42018251-42055199",
                            "ensembl_id": "ENSG00000137413"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "6:42050513-42087461",
                            "ensembl_id": "ENSG00000137413"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2007-07-30"
            },
            "entity_type": "gene",
            "entity_name": "TAF8",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "29648665",
                "35759269"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Neurodevelopmental disorder with severe motor impairment, absent language, cerebral hypomyelination, and brain atrophy, MIM# 619972"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:6817",
                "gene_name": "mal, T-cell differentiation protein",
                "omim_gene": [
                    "188860"
                ],
                "alias_name": [
                    "MyD88-adapter-like"
                ],
                "gene_symbol": "MAL",
                "hgnc_symbol": "MAL",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "2:95691422-95719737",
                            "ensembl_id": "ENSG00000172005"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "2:95025677-95053996",
                            "ensembl_id": "ENSG00000172005"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1986-01-01"
            },
            "entity_type": "gene",
            "entity_name": "MAL",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "35217805"
            ],
            "evidence": [
                "Expert Review Amber",
                "Literature"
            ],
            "phenotypes": [
                "Leukodystrophy, hypomyelinating, 28, MIM#  620978"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "DKFZp434P0111",
                    "CSC1",
                    "hsCSC1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:23787",
                "gene_name": "transmembrane protein 63C",
                "omim_gene": null,
                "alias_name": [
                    "calcium permeable stress-gated cation channel 1 homolog (Arabidopsis)"
                ],
                "gene_symbol": "TMEM63C",
                "hgnc_symbol": "TMEM63C",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "14:77582911-77725838",
                            "ensembl_id": "ENSG00000165548"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "14:77116568-77259495",
                            "ensembl_id": "ENSG00000165548"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2005-07-25"
            },
            "entity_type": "gene",
            "entity_name": "TMEM63C",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "PMID: 35718349"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Spastic paraplegia 87, autosomal recessive, MIM# 619966"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:12787",
                "gene_name": "Wnt family member 7B",
                "omim_gene": [
                    "601967"
                ],
                "alias_name": null,
                "gene_symbol": "WNT7B",
                "hgnc_symbol": "WNT7B",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "22:46316242-46373009",
                            "ensembl_id": "ENSG00000188064"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "22:45920362-45977129",
                            "ensembl_id": "ENSG00000188064"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1997-04-21"
            },
            "entity_type": "gene",
            "entity_name": "WNT7B",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "35790350"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Pulmonary hypoplasia, Diaphragmatic anomalies, Anophthalmia/microphthalmia and Cardiac defects syndrome",
                "Multiple congenital anomalies/dysmorphic features syndrome MONDO:0043005, WNT7B-related"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:14543",
                "gene_name": "WNK lysine deficient protein kinase 3",
                "omim_gene": [
                    "300358"
                ],
                "alias_name": null,
                "gene_symbol": "WNK3",
                "hgnc_symbol": "WNK3",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "X:54219256-54385075",
                            "ensembl_id": "ENSG00000196632"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "X:54192823-54358642",
                            "ensembl_id": "ENSG00000196632"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2005-01-22"
            },
            "entity_type": "gene",
            "entity_name": "WNK3",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "35678782"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Prieto syndrome, MIM# 309610"
            ],
            "mode_of_inheritance": "X-LINKED: hemizygous mutation in males, biallelic mutations in females",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "NEDF",
                    "CGI-149"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:29865",
                "gene_name": "charged multivesicular body protein 3",
                "omim_gene": [
                    "610052"
                ],
                "alias_name": null,
                "gene_symbol": "CHMP3",
                "hgnc_symbol": "CHMP3",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "2:86730554-86948245",
                            "ensembl_id": "ENSG00000115561"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "2:86503431-86563479",
                            "ensembl_id": "ENSG00000115561"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2011-09-21"
            },
            "entity_type": "gene",
            "entity_name": "CHMP3",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "PMID: 35710109"
            ],
            "evidence": [
                "Expert Review Amber",
                "Literature"
            ],
            "phenotypes": [
                "Hereditary spastic paraplegia (MONDO:0019064), CHMP3-related"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "PABP1",
                    "PABPL1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:8554",
                "gene_name": "poly(A) binding protein cytoplasmic 1",
                "omim_gene": [
                    "604679"
                ],
                "alias_name": null,
                "gene_symbol": "PABPC1",
                "hgnc_symbol": "PABPC1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "8:101698044-101735037",
                            "ensembl_id": "ENSG00000070756"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "8:100685816-100722809",
                            "ensembl_id": "ENSG00000070756"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1992-09-28"
            },
            "entity_type": "gene",
            "entity_name": "PABPC1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "PMID: 35511136"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Neurodevelopmental disorder, PABPC1-related (MONDO#0700092)"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "ZnTL2",
                    "ZNT7"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:19306",
                "gene_name": "solute carrier family 30 member 7",
                "omim_gene": [
                    "611149"
                ],
                "alias_name": null,
                "gene_symbol": "SLC30A7",
                "hgnc_symbol": "SLC30A7",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "1:101361632-101447309",
                            "ensembl_id": "ENSG00000162695"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "1:100896076-100981753",
                            "ensembl_id": "ENSG00000162695"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2003-03-14"
            },
            "entity_type": "gene",
            "entity_name": "SLC30A7",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "PMID: 35751429"
            ],
            "evidence": [
                "Expert Review Amber",
                "Literature"
            ],
            "phenotypes": [
                "Joubert syndrome (MONDO:0018772), SLC30A7-related"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ32658",
                    "KASH5"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:26520",
                "gene_name": "coiled-coil domain containing 155",
                "omim_gene": null,
                "alias_name": null,
                "gene_symbol": "CCDC155",
                "hgnc_symbol": "CCDC155",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "19:49891475-49921251",
                            "ensembl_id": "ENSG00000161609"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "19:49388218-49417994",
                            "ensembl_id": "ENSG00000161609"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2008-08-07"
            },
            "entity_type": "gene",
            "entity_name": "CCDC155",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "35674372",
                "35708642",
                "29790874",
                "35587281"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Non-obstructive azoospermia",
                "Premature ovarian insufficiency",
                "Infertility disorder, MONDO:0005047, CCDC155-related"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [
                "new gene name"
            ],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "C2-PI3K",
                    "PI3K-C2beta"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:8972",
                "gene_name": "phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta",
                "omim_gene": [
                    "602838"
                ],
                "alias_name": null,
                "gene_symbol": "PIK3C2B",
                "hgnc_symbol": "PIK3C2B",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "1:204391756-204463852",
                            "ensembl_id": "ENSG00000133056"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "1:204422628-204494724",
                            "ensembl_id": "ENSG00000133056"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1998-05-21"
            },
            "entity_type": "gene",
            "entity_name": "PIK3C2B",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "PMID:35786744"
            ],
            "evidence": [
                "Expert Review Amber",
                "Literature"
            ],
            "phenotypes": [
                "familial partial epilepsy - MONDO#0017704"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "NF-ATP",
                    "NFATp",
                    "NFAT1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7776",
                "gene_name": "nuclear factor of activated T-cells 2",
                "omim_gene": [
                    "600490"
                ],
                "alias_name": null,
                "gene_symbol": "NFATC2",
                "hgnc_symbol": "NFATC2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "20:50003494-50179370",
                            "ensembl_id": "ENSG00000101096"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "20:51386957-51562831",
                            "ensembl_id": "ENSG00000101096"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1994-11-16"
            },
            "entity_type": "gene",
            "entity_name": "NFATC2",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "35789258",
                "38427060"
            ],
            "evidence": [
                "Expert Review Red",
                "ClinGen",
                "Expert Review Amber",
                "Literature"
            ],
            "phenotypes": [
                "Skeletal system disorder MONDO:0005172",
                "Lymphoproliferative syndrome, MONDO:0016537, NFATC2-related"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "JTK9"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:4840",
                "gene_name": "HCK proto-oncogene, Src family tyrosine kinase",
                "omim_gene": [
                    "142370"
                ],
                "alias_name": null,
                "gene_symbol": "HCK",
                "hgnc_symbol": "HCK",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "20:30639991-30689659",
                            "ensembl_id": "ENSG00000101336"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "20:32052188-32101856",
                            "ensembl_id": "ENSG00000101336"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1986-01-01"
            },
            "entity_type": "gene",
            "entity_name": "HCK",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": "Other",
            "publications": [
                "34536415"
            ],
            "evidence": [
                "Expert Review Amber",
                "Literature"
            ],
            "phenotypes": [
                "Autoinflammation with pulmonary and cutaneous vasculitis, MIM#620296"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "CPETRL1",
                    "BEC1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:2047",
                "gene_name": "claudin 5",
                "omim_gene": [
                    "602101"
                ],
                "alias_name": null,
                "gene_symbol": "CLDN5",
                "hgnc_symbol": "CLDN5",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "22:19510547-19515068",
                            "ensembl_id": "ENSG00000184113"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "22:19523024-19527545",
                            "ensembl_id": "ENSG00000184113"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1997-03-19"
            },
            "entity_type": "gene",
            "entity_name": "CLDN5",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "35714222",
                "36477332"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Syndromic disorder, MONDO:0002254, CLDN5-related"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ32779"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:26535",
                "gene_name": "chromosome 9 open reading frame 84",
                "omim_gene": null,
                "alias_name": null,
                "gene_symbol": "C9orf84",
                "hgnc_symbol": "C9orf84",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "9:114448453-114557288",
                            "ensembl_id": "ENSG00000165181"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "9:111686173-111795008",
                            "ensembl_id": "ENSG00000165181"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2004-01-29"
            },
            "entity_type": "gene",
            "entity_name": "C9orf84",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "32741963",
                "32900840",
                "35485979"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Spermatogenic failure 75, MIM#\t619949"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [
                "new gene name"
            ],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ13912",
                    "PSF3"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:25851",
                "gene_name": "GINS complex subunit 3",
                "omim_gene": [
                    "610610"
                ],
                "alias_name": null,
                "gene_symbol": "GINS3",
                "hgnc_symbol": "GINS3",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "16:58328984-58440048",
                            "ensembl_id": "ENSG00000181938"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "16:58295080-58406144",
                            "ensembl_id": "ENSG00000181938"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2006-05-04"
            },
            "entity_type": "gene",
            "entity_name": "GINS3",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "35603789"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Meier-Gorlin syndrome 9, MIM# 621512"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "PNAS-11",
                    "RIP5"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:15870",
                "gene_name": "chromosome 20 open reading frame 24",
                "omim_gene": null,
                "alias_name": null,
                "gene_symbol": "C20orf24",
                "hgnc_symbol": "C20orf24",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "20:35234137-35240960",
                            "ensembl_id": "ENSG00000101084"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "20:36605734-36612557",
                            "ensembl_id": "ENSG00000101084"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2001-06-21"
            },
            "entity_type": "gene",
            "entity_name": "C20orf24",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "35614220",
                "24194475"
            ],
            "evidence": [
                "Expert Review Red",
                "Literature"
            ],
            "phenotypes": [
                "Craniofacial dysmorphism, skeletal anomalies, and impaired intellectual development syndrome 2, MIM# \t616994"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [
                "new gene name"
            ],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "HNRBP2",
                    "FOX-2",
                    "HRNBP2"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:9906",
                "gene_name": "RNA binding fox-1 homolog 2",
                "omim_gene": [
                    "612149"
                ],
                "alias_name": [
                    "hexaribonucleotide binding protein 2"
                ],
                "gene_symbol": "RBFOX2",
                "hgnc_symbol": "RBFOX2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "22:36134783-36424473",
                            "ensembl_id": "ENSG00000100320"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "22:35738736-36028425",
                            "ensembl_id": "ENSG00000100320"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2010-09-10"
            },
            "entity_type": "gene",
            "entity_name": "RBFOX2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "PMID: 26785492",
                "27670201",
                "27485310",
                "25205790",
                "35137168"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "RBFOX2-related congenital heart disorder (MONDO:0100557)"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:243",
                "gene_name": "adducin 1",
                "omim_gene": [
                    "102680"
                ],
                "alias_name": [
                    "alpha-adducin"
                ],
                "gene_symbol": "ADD1",
                "hgnc_symbol": "ADD1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "4:2845584-2931803",
                            "ensembl_id": "ENSG00000087274"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "4:2843857-2930076",
                            "ensembl_id": "ENSG00000087274"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1992-10-19"
            },
            "entity_type": "gene",
            "entity_name": "ADD1",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "PMID: 34906466"
            ],
            "evidence": [
                "Expert Review Amber",
                "Literature"
            ],
            "phenotypes": [
                "Neurodevelopmental disorder MONDO:0700092, ADD1-related"
            ],
            "mode_of_inheritance": "BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "ER71"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:3491",
                "gene_name": "ETS variant 2",
                "omim_gene": [
                    "609358"
                ],
                "alias_name": null,
                "gene_symbol": "ETV2",
                "hgnc_symbol": "ETV2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "19:36132647-36135773",
                            "ensembl_id": "ENSG00000105672"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "19:35641745-35644871",
                            "ensembl_id": "ENSG00000105672"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1994-05-02"
            },
            "entity_type": "gene",
            "entity_name": "ETV2",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "33359164"
            ],
            "evidence": [
                "Expert Review Red",
                "Literature"
            ],
            "phenotypes": [
                "multiple fetal anomalies",
                "congenital heart disease MONDO:000545, ETV2-related",
                "vertebral malformations"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "NYD-SP20"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:30705",
                "gene_name": "spermatogenesis associated 22",
                "omim_gene": [
                    "617673"
                ],
                "alias_name": null,
                "gene_symbol": "SPATA22",
                "hgnc_symbol": "SPATA22",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "17:3343313-3417146",
                            "ensembl_id": "ENSG00000141255"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "17:3440019-3513852",
                            "ensembl_id": "ENSG00000141255"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2005-12-19"
            },
            "entity_type": "gene",
            "entity_name": "SPATA22",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "34392356",
                "35413094",
                "35285020"
            ],
            "evidence": [
                "Expert Review Green",
                "Expert Review"
            ],
            "phenotypes": [
                "Spermatogenic failure 96, MIM#621001",
                "Premature ovarian failure 25, MIM#621002"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "bA50D16.2",
                    "FLJ12661"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:20291",
                "gene_name": "proline and serine rich 1",
                "omim_gene": null,
                "alias_name": null,
                "gene_symbol": "PROSER1",
                "hgnc_symbol": "PROSER1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "13:39584003-39612252",
                            "ensembl_id": "ENSG00000120685"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "13:39009866-39038076",
                            "ensembl_id": "ENSG00000120685"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2011-08-09"
            },
            "entity_type": "gene",
            "entity_name": "PROSER1",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "35229282"
            ],
            "evidence": [
                "Expert Review Red",
                "Expert Review"
            ],
            "phenotypes": [
                "Syndromic disease MONDO:0002254, PROSER1-related"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [
                "founder"
            ],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "N-WASP",
                    "NWASP",
                    "WASPB"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:12735",
                "gene_name": "Wiskott-Aldrich syndrome like",
                "omim_gene": [
                    "605056"
                ],
                "alias_name": null,
                "gene_symbol": "WASL",
                "hgnc_symbol": "WASL",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "7:123321989-123389121",
                            "ensembl_id": "ENSG00000106299"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "7:123681935-123749067",
                            "ensembl_id": "ENSG00000106299"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1998-10-14"
            },
            "entity_type": "gene",
            "entity_name": "WASL",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "33571872"
            ],
            "evidence": [
                "Expert Review Red",
                "Literature"
            ],
            "phenotypes": [
                "Parkinson's disease, MONDO:0005180, WASL-related"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ38547",
                    "PGR21"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:13839",
                "gene_name": "adhesion G protein-coupled receptor A3",
                "omim_gene": [
                    "612303"
                ],
                "alias_name": null,
                "gene_symbol": "ADGRA3",
                "hgnc_symbol": "ADGRA3",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "4:22346694-22517677",
                            "ensembl_id": "ENSG00000152990"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "4:22345071-22516054",
                            "ensembl_id": "ENSG00000152990"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2015-03-03"
            },
            "entity_type": "gene",
            "entity_name": "ADGRA3",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "23105016"
            ],
            "evidence": [
                "Expert Review Red",
                "Expert Review"
            ],
            "phenotypes": [
                "Retinitis pigmentosa, MONDO:0019200, ADGRA3-related"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ21511",
                    "CWH43-C"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:26133",
                "gene_name": "cell wall biogenesis 43 C-terminal homolog",
                "omim_gene": null,
                "alias_name": null,
                "gene_symbol": "CWH43",
                "hgnc_symbol": "CWH43",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "4:48988264-49064098",
                            "ensembl_id": "ENSG00000109182"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "4:48986247-49062081",
                            "ensembl_id": "ENSG00000109182"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2009-07-28"
            },
            "entity_type": "gene",
            "entity_name": "CWH43",
            "confidence_level": "1",
            "penetrance": "Incomplete",
            "mode_of_pathogenicity": null,
            "publications": [
                "PMID: 33459505",
                "34380733"
            ],
            "evidence": [
                "Expert Review Red",
                "Literature"
            ],
            "phenotypes": [
                "Hydrocephalus MONDO:0001150, CWH43-related"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [
                "cnv"
            ],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "KIAA0821",
                    "CIRL1",
                    "LEC2"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:20973",
                "gene_name": "adhesion G protein-coupled receptor L1",
                "omim_gene": [
                    "616416"
                ],
                "alias_name": null,
                "gene_symbol": "ADGRL1",
                "hgnc_symbol": "ADGRL1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "19:14260750-14316999",
                            "ensembl_id": "ENSG00000072071"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "19:14147743-14206187",
                            "ensembl_id": "ENSG00000072071"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2015-03-03"
            },
            "entity_type": "gene",
            "entity_name": "ADGRL1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "PMID: 35907405"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Developmental delay, behavioral abnormalities, and neuropsychiatric disorders, MIM# 620065"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ23458"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:31690",
                "gene_name": "chromosome 18 open reading frame 32",
                "omim_gene": null,
                "alias_name": null,
                "gene_symbol": "C18orf32",
                "hgnc_symbol": "C18orf32",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "18:47008028-47013622",
                            "ensembl_id": "ENSG00000177576"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "18:49477250-49487252",
                            "ensembl_id": "ENSG00000177576"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2007-08-02"
            },
            "entity_type": "gene",
            "entity_name": "C18orf32",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "PMID:35107634"
            ],
            "evidence": [
                "Expert Review Red",
                "Literature"
            ],
            "phenotypes": [
                "Neurodevelopmental disorder (MONDO:0700092), C18orf32-related"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "KIAA1854",
                    "CXorf2"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:13449",
                "gene_name": "SLIT and NTRK like family member 2",
                "omim_gene": [
                    "300561"
                ],
                "alias_name": null,
                "gene_symbol": "SLITRK2",
                "hgnc_symbol": "SLITRK2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "X:144899350-144907360",
                            "ensembl_id": "ENSG00000185985"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "X:145817832-145825842",
                            "ensembl_id": "ENSG00000185985"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2004-03-11"
            },
            "entity_type": "gene",
            "entity_name": "SLITRK2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "35840571"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Intellectual developmental disorder, X-linked 111, MIM# 301107"
            ],
            "mode_of_inheritance": "X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "MGC4293"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:28662",
                "gene_name": "deoxyhypusine hydroxylase",
                "omim_gene": [
                    "611262"
                ],
                "alias_name": null,
                "gene_symbol": "DOHH",
                "hgnc_symbol": "DOHH",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "19:3490819-3500938",
                            "ensembl_id": "ENSG00000129932"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "19:3490822-3500940",
                            "ensembl_id": "ENSG00000129932"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2006-05-22"
            },
            "entity_type": "gene",
            "entity_name": "DOHH",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "PMID: 35858628"
            ],
            "evidence": [
                "Expert Review Green",
                "Expert list"
            ],
            "phenotypes": [
                "Neurodevelopmental disorder with microcephaly, cerebral atrophy, and visual impairment, MIM# 620066"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "bA421P11.2"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:20266",
                "gene_name": "ALG5, dolichyl-phosphate beta-glucosyltransferase",
                "omim_gene": [
                    "604565"
                ],
                "alias_name": null,
                "gene_symbol": "ALG5",
                "hgnc_symbol": "ALG5",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "13:37523912-37574398",
                            "ensembl_id": "ENSG00000120697"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "13:36949775-37000261",
                            "ensembl_id": "ENSG00000120697"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2003-10-15"
            },
            "entity_type": "gene",
            "entity_name": "ALG5",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "35896117"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Polycystic kidney disease 7, MIM# 620056"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:1070",
                "gene_name": "bone morphogenetic protein 3",
                "omim_gene": [
                    "112263"
                ],
                "alias_name": [
                    "osteogenin"
                ],
                "gene_symbol": "BMP3",
                "hgnc_symbol": "BMP3",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "4:81952119-81978685",
                            "ensembl_id": "ENSG00000152785"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "4:81030965-81057531",
                            "ensembl_id": "ENSG00000152785"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1990-06-11"
            },
            "entity_type": "gene",
            "entity_name": "BMP3",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "35089417"
            ],
            "evidence": [
                "Expert Review Amber",
                "Literature"
            ],
            "phenotypes": [
                "coloboma, MONDO:0001476",
                "microphthalmia, MONDO:0021129"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "HKLP2",
                    "NY-BR-62"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:17273",
                "gene_name": "kinesin family member 15",
                "omim_gene": [
                    "617569"
                ],
                "alias_name": null,
                "gene_symbol": "KIF15",
                "hgnc_symbol": "KIF15",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "3:44803209-44914868",
                            "ensembl_id": "ENSG00000163808"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "3:44761717-44873376",
                            "ensembl_id": "ENSG00000163808"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2005-03-17"
            },
            "entity_type": "gene",
            "entity_name": "KIF15",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "28150392"
            ],
            "evidence": [
                "Expert Review Red",
                "Literature"
            ],
            "phenotypes": [
                "Braddock-Carey syndrome 2 - MIM#619981"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "S4",
                    "p56"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:9547",
                "gene_name": "proteasome 26S subunit, ATPase 1",
                "omim_gene": [
                    "602706"
                ],
                "alias_name": null,
                "gene_symbol": "PSMC1",
                "hgnc_symbol": "PSMC1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "14:90722839-90738968",
                            "ensembl_id": "ENSG00000100764"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "14:90256495-90275429",
                            "ensembl_id": "ENSG00000100764"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1995-11-27"
            },
            "entity_type": "gene",
            "entity_name": "PSMC1",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "PMID: 35861243"
            ],
            "evidence": [
                "Expert Review Red",
                "Literature"
            ],
            "phenotypes": [
                "Birk-Aharoni syndrome MIM# 620071"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "NOH1",
                    "NOH-1",
                    "MOX1",
                    "GP91-2"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7889",
                "gene_name": "NADPH oxidase 1",
                "omim_gene": [
                    "300225"
                ],
                "alias_name": [
                    "mitogenic oxidase (pyridine nucleotide-dependent superoxide-generating)",
                    "NADPH oxidase homolog-1",
                    "NADPH oxidase 1 variant NOH-1L"
                ],
                "gene_symbol": "NOX1",
                "hgnc_symbol": "NOX1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "X:100098313-100129334",
                            "ensembl_id": "ENSG00000007952"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "X:100843324-100874345",
                            "ensembl_id": "ENSG00000007952"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2000-03-24"
            },
            "entity_type": "gene",
            "entity_name": "NOX1",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "29091079",
                "32064493"
            ],
            "evidence": [
                "Literature",
                "Literature"
            ],
            "phenotypes": [
                "Inflammatory bowel disease, MONDO:0005265, NOX1-related"
            ],
            "mode_of_inheritance": "X-LINKED: hemizygous mutation in males, biallelic mutations in females",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "RACK7"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:9397",
                "gene_name": "zinc finger MYND-type containing 8",
                "omim_gene": [
                    "615713"
                ],
                "alias_name": null,
                "gene_symbol": "ZMYND8",
                "hgnc_symbol": "ZMYND8",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "20:45837859-45985567",
                            "ensembl_id": "ENSG00000101040"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "20:47209214-47356889",
                            "ensembl_id": "ENSG00000101040"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2007-01-29"
            },
            "entity_type": "gene",
            "entity_name": "ZMYND8",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "35916866",
                "32530565"
            ],
            "evidence": [
                "Expert Review Green",
                "Expert Review"
            ],
            "phenotypes": [
                "Neurodevelopmental disorder, MONDO:0700092, ZMYND8-related",
                "Delayed speech and language development",
                "Motor delay",
                "Intellectual disability",
                "Abnormality of cardiovascular system morphology",
                "Hearing abnormality",
                "Abnormality of vision",
                "Abnormality of the face",
                "Seizures"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ20375"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:23377",
                "gene_name": "focadhesin",
                "omim_gene": [
                    "614606"
                ],
                "alias_name": null,
                "gene_symbol": "FOCAD",
                "hgnc_symbol": "FOCAD",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "9:20658308-20995954",
                            "ensembl_id": "ENSG00000188352"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "9:20658309-20995955",
                            "ensembl_id": "ENSG00000188352"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2012-03-23"
            },
            "entity_type": "gene",
            "entity_name": "FOCAD",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "35864190"
            ],
            "evidence": [
                "Expert Review Green",
                "Expert Review"
            ],
            "phenotypes": [
                "Liver disease, severe congenital, MIM# 619991"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "KNS"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:6324",
                "gene_name": "kinesin family member 5B",
                "omim_gene": [
                    "602809"
                ],
                "alias_name": null,
                "gene_symbol": "KIF5B",
                "hgnc_symbol": "KIF5B",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "10:32297938-32345359",
                            "ensembl_id": "ENSG00000170759"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "10:32009010-32056431",
                            "ensembl_id": "ENSG00000170759"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1998-08-24"
            },
            "entity_type": "gene",
            "entity_name": "KIF5B",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "PMID: 35342932",
                "36018820",
                "37934770"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "osteogenesis imperfecta, MONDO:0019019, KIF5B-related",
                "Skeletal dysplasia, MONDO:0018230, KIF5B-related"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "EGFL6L",
                    "POEM"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:27405",
                "gene_name": "nephronectin",
                "omim_gene": [
                    "610306"
                ],
                "alias_name": null,
                "gene_symbol": "NPNT",
                "hgnc_symbol": "NPNT",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "4:106815932-106925184",
                            "ensembl_id": "ENSG00000168743"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "4:105894775-106004027",
                            "ensembl_id": "ENSG00000168743"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2005-10-07"
            },
            "entity_type": "gene",
            "entity_name": "NPNT",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "35246978",
                "34049960",
                "17537792"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Renal agenesis, MONDO:0018470, NPNT-related"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ23518"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:26282",
                "gene_name": "coiled-coil domain containing 82",
                "omim_gene": null,
                "alias_name": null,
                "gene_symbol": "CCDC82",
                "hgnc_symbol": "CCDC82",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "11:96085933-96123087",
                            "ensembl_id": "ENSG00000149231"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "11:96352769-96389923",
                            "ensembl_id": "ENSG00000149231"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2006-03-09"
            },
            "entity_type": "gene",
            "entity_name": "CCDC82",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "35373332",
                "35118659",
                "27457812"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Neurodevelopmental disorder, MONDO:0700092, CCDC82-related"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "Lhx7"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:28838",
                "gene_name": "LIM homeobox 8",
                "omim_gene": [
                    "604425"
                ],
                "alias_name": null,
                "gene_symbol": "LHX8",
                "hgnc_symbol": "LHX8",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "1:75594119-75627218",
                            "ensembl_id": "ENSG00000162624"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "1:75128434-75161533",
                            "ensembl_id": "ENSG00000162624"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2005-06-02"
            },
            "entity_type": "gene",
            "entity_name": "LHX8",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "36029299"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Inherited premature ovarian failure, MONDO:0019852, LHX8-related"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "caprin-1",
                    "RNG105"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:6743",
                "gene_name": "cell cycle associated protein 1",
                "omim_gene": [
                    "601178"
                ],
                "alias_name": [
                    "cytoplasmic activation/proliferation-associated protein-1"
                ],
                "gene_symbol": "CAPRIN1",
                "hgnc_symbol": "CAPRIN1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "11:34073230-34122703",
                            "ensembl_id": "ENSG00000135387"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "11:34051683-34101156",
                            "ensembl_id": "ENSG00000135387"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2007-03-27"
            },
            "entity_type": "gene",
            "entity_name": "CAPRIN1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "35979925",
                "36136249"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Neurodevelopmental disorder with language impairment, autism, and attention deficit-hyperactivity disorder, MIM#\t620782",
                "Neurodegeneration, childhood-onset, with cerebellar ataxia and cognitive decline, MIM# 620636"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:16305",
                "gene_name": "ADAM metallopeptidase with thrombospondin type 1 motif 15",
                "omim_gene": [
                    "607509"
                ],
                "alias_name": null,
                "gene_symbol": "ADAMTS15",
                "hgnc_symbol": "ADAMTS15",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "11:130318869-130346532",
                            "ensembl_id": "ENSG00000166106"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "11:130448974-130476641",
                            "ensembl_id": "ENSG00000166106"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2002-02-13"
            },
            "entity_type": "gene",
            "entity_name": "ADAMTS15",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "PMID: 35962790"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Arthrogryposis, distal, type 12, MIM# 620545"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "MGC13125",
                    "fSAP71",
                    "Cwc26"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:28199",
                "gene_name": "BUD13 homolog",
                "omim_gene": null,
                "alias_name": [
                    "functional spliceosome-associated protein 71"
                ],
                "gene_symbol": "BUD13",
                "hgnc_symbol": "BUD13",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "11:116618886-116643704",
                            "ensembl_id": "ENSG00000137656"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "11:116748170-116772988",
                            "ensembl_id": "ENSG00000137656"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2006-03-10"
            },
            "entity_type": "gene",
            "entity_name": "BUD13",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "35670808"
            ],
            "evidence": [
                "Expert Review Amber",
                "Literature"
            ],
            "phenotypes": [
                "Achalasia-progeroid syndrome, MIM# 621123"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:18711",
                "gene_name": "leucine rich repeat LGI family member 3",
                "omim_gene": [
                    "608302"
                ],
                "alias_name": null,
                "gene_symbol": "LGI3",
                "hgnc_symbol": "LGI3",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "8:22004338-22014597",
                            "ensembl_id": "ENSG00000168481"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "8:22146825-22157084",
                            "ensembl_id": "ENSG00000168481"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2002-05-30"
            },
            "entity_type": "gene",
            "entity_name": "LGI3",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "PMID: 35948005"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Neurodevelopmental disorder, MONDO:0700092, LGI3-related",
                "Global developmental delay",
                "Intellectual disability",
                "Distal deformities",
                "Diminished reflexes",
                "Facial myokymia",
                "Hyporeflexia/areflexi"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "DKFZP566N034",
                    "SV31"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:25380",
                "gene_name": "transmembrane protein 163",
                "omim_gene": null,
                "alias_name": null,
                "gene_symbol": "TMEM163",
                "hgnc_symbol": "TMEM163",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "2:135213330-135476570",
                            "ensembl_id": "ENSG00000152128"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "2:134455759-134719000",
                            "ensembl_id": "ENSG00000152128"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2006-07-04"
            },
            "entity_type": "gene",
            "entity_name": "TMEM163",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "PMID: 35953447"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Hypomyelinating leukodystrophy, MONDO:0019046"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "Tsase",
                    "TMS",
                    "HsT422"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:12441",
                "gene_name": "thymidylate synthetase",
                "omim_gene": [
                    "188350"
                ],
                "alias_name": null,
                "gene_symbol": "TYMS",
                "hgnc_symbol": "TYMS",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "18:657604-673578",
                            "ensembl_id": "ENSG00000176890"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "18:657604-673578",
                            "ensembl_id": "ENSG00000176890"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1990-09-10"
            },
            "entity_type": "gene",
            "entity_name": "TYMS",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "35931051"
            ],
            "evidence": [
                "Expert Review Amber",
                "Literature"
            ],
            "phenotypes": [
                "Dyskeratosis congenita, digenic, MIM#620040"
            ],
            "mode_of_inheritance": "Other",
            "tags": [
                "digenic"
            ],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "RNF56",
                    "Cbl-b"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:1542",
                "gene_name": "Cbl proto-oncogene B",
                "omim_gene": [
                    "604491"
                ],
                "alias_name": null,
                "gene_symbol": "CBLB",
                "hgnc_symbol": "CBLB",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "3:105374305-105588396",
                            "ensembl_id": "ENSG00000114423"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "3:105655461-105869552",
                            "ensembl_id": "ENSG00000114423"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1995-12-18"
            },
            "entity_type": "gene",
            "entity_name": "CBLB",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "36006710"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Autoimmune disease, multisystem, infantile-onset, 3, MIM#\t620430"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "NIFIE14",
                    "MGC1936"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:30414",
                "gene_name": "transmembrane protein 147",
                "omim_gene": [
                    "613585"
                ],
                "alias_name": null,
                "gene_symbol": "TMEM147",
                "hgnc_symbol": "TMEM147",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "19:36036497-36038428",
                            "ensembl_id": "ENSG00000105677"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "19:35545595-35547526",
                            "ensembl_id": "ENSG00000105677"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2006-03-31"
            },
            "entity_type": "gene",
            "entity_name": "TMEM147",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "PMID: 36044892"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Neurodevelopmental disorder with facial dysmorphism, absent language, and pseudo-Pelger-Huet anomaly, MIM# 620075"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "COX11P"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:2261",
                "gene_name": "COX11, cytochrome c oxidase copper chaperone",
                "omim_gene": [
                    "603648"
                ],
                "alias_name": [
                    "cytochrome c oxidase subunit 11",
                    "cytochrome c oxidase assembly protein COX11"
                ],
                "gene_symbol": "COX11",
                "hgnc_symbol": "COX11",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "17:53029263-53046146",
                            "ensembl_id": "ENSG00000166260"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "17:54951902-54968785",
                            "ensembl_id": "ENSG00000166260"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1998-07-03"
            },
            "entity_type": "gene",
            "entity_name": "COX11",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "36030551"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Mitochondrial disease (MONDO:0044970), COX11-related"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4785",
                "version_created": "2026-04-24T16:55:45.472882+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6015,
                    "number_of_strs": 43,
                    "number_of_regions": 8
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        }
    ]
}